Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Aging (Albany NY) ; 13(17): 20935-20961, 2021 09 09.
Article in English | MEDLINE | ID: mdl-34499614

ABSTRACT

Vascular dysfunction is entwined with aging and in the pathogenesis of Alzheimer's disease (AD) and contributes to reduced cerebral blood flow (CBF) and consequently, hypoxia. Hyperbaric oxygen therapy (HBOT) is in clinical use for a wide range of medical conditions. In the current study, we exposed 5XFAD mice, a well-studied AD model that presents impaired cognitive abilities, to HBOT and then investigated the therapeutical effects using two-photon live animal imaging, behavioral tasks, and biochemical and histological analysis. HBOT increased arteriolar luminal diameter and elevated CBF, thus contributing to reduced hypoxia. Furthermore, HBOT reduced amyloid burden by reducing the volume of pre-existing plaques and attenuating the formation of new ones. This was associated with changes in amyloid precursor protein processing, elevated degradation and clearance of Aß protein and improved behavior of 5XFAD mice. Hence, our findings are consistent with the effects of HBOT being mediated partially through a persistent structural change in blood vessels that reduces brain hypoxia. Motivated by these findings, we exposed elderly patients with significant memory loss at baseline to HBOT and observed an increase in CBF and improvement in cognitive performances. This study demonstrates HBOT efficacy in hypoxia-related neurological conditions, particularly in AD and aging.


Subject(s)
Alzheimer Disease/therapy , Amyloid beta-Peptides/metabolism , Hyperbaric Oxygenation , Aged , Alzheimer Disease/diagnostic imaging , Amyloid beta-Protein Precursor/metabolism , Animals , Behavior, Animal , Cerebrovascular Circulation , Cognitive Dysfunction/metabolism , Female , Humans , Male , Memory Disorders/metabolism , Mice , Mice, Transgenic , Middle Aged , Plaque, Amyloid/metabolism
2.
Nano Lett ; 19(6): 3422-3431, 2019 06 12.
Article in English | MEDLINE | ID: mdl-30761901

ABSTRACT

Exosomes, nanovesicles that are secreted by different cell types, enable intercellular communication at local or distant sites. Alhough they have been found to cross the blood brain barrier, their migration and homing abilities within the brain remain unstudied. We have recently developed a method for longitudinal and quantitative in vivo neuroimaging of exosomes based on the superior visualization abilities of classical X-ray computed tomography (CT), combined with gold nanoparticles as labeling agents. Here, we used this technique to track the migration and homing patterns of intranasally administrated exosomes derived from bone marrow mesenchymal stem cells (MSC-exo) in different brain pathologies, including stroke, autism, Parkinson's disease, and Alzheimer's disease. We found that MSC-exo specifically targeted and accumulated in pathologically relevant murine models brains regions up to 96 h post administration, while in healthy controls they showed a diffuse migration pattern and clearance by 24 h. The neuro-inflammatory signal in pathological brains was highly correlated with MSC-exo accumulation, suggesting that the homing mechanism is inflammatory-driven. In addition, MSC-exo were selectively uptaken by neuronal cells, but not glial cells, in the pathological regions. Taken together, these findings can significantly promote the application of exosomes for therapy and targeted drug delivery in various brain pathologies.


Subject(s)
Brain/diagnostic imaging , Exosomes , Neurodegenerative Diseases/diagnostic imaging , Neurodevelopmental Disorders/diagnostic imaging , Alzheimer Disease/diagnostic imaging , Animals , Disease Models, Animal , Exosomes/chemistry , Gold/analysis , Mesenchymal Stem Cells/chemistry , Metal Nanoparticles/analysis , Neuroimaging/methods , Tomography, X-Ray Computed/methods
4.
Neurobiol Aging ; 62: 105-119, 2018 02.
Article in English | MEDLINE | ID: mdl-29141186

ABSTRACT

There is a real need for new interventions for Alzheimer's disease (AD). Hyperbaric oxygen therapy (HBOT), the medical administration of 100% oxygen at conditions greater than 1 atmosphere absolute, has been used successfully to treat several neurological conditions, but its effects on AD pathology have never been thoroughly examined. Therefore, we exposed old triple-transgenic (3xTg) and non-transgenic mice to HBOT followed by behavioral, histological, and biochemical analyses. HBOT attenuated neuroinflammatory processes by reducing astrogliosis, microgliosis, and the secretion of proinflammatory cytokines (IL-1ß and TNFα) and increasing expression of scavenger receptor A, arginase1, and antiinflammatory cytokines (IL-4 and IL-10). Moreover, HBOT reduced hypoxia, amyloid burden, and tau phosphorylation in 3xTg mice and ameliorated their behavioral deficits. Therefore, we suggest that HBOT has multifaceted effects that reduce AD pathologies, even in old mice. Given that HBOT is used in the clinic to treat various indications, including neurological conditions, these results suggest HBOT as a novel therapeutic intervention for AD.


Subject(s)
Alzheimer Disease/therapy , Hyperbaric Oxygenation/methods , Inflammation/therapy , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Alzheimer Disease/psychology , Amyloid beta-Peptides/metabolism , Animals , Arginase/metabolism , Astrocytes/pathology , Behavior, Animal , Cytokines/metabolism , Disease Models, Animal , Hypoxia/therapy , Inflammation/metabolism , Inflammation/pathology , Inflammation Mediators/metabolism , Mice, Inbred C57BL , Mice, Transgenic , Microglia/pathology , Phosphorylation , Scavenger Receptors, Class A/metabolism , tau Proteins/metabolism
5.
Cereb Cortex ; 24(9): 2309-23, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23537531

ABSTRACT

Alterations in the levels of synaptic proteins affect synaptic transmission and synaptic plasticity. However, the precise effects on neuronal network activity are still enigmatic. Here, we utilized microelectrode array (MEA) to elucidate how manipulation of the presynaptic release process affects the activity of neuronal networks. By combining pharmacological tools and genetic manipulation of synaptic proteins, we show that overexpression of DOC2B and Munc13-1, proteins known to promote vesicular maturation and release, elicits opposite effects on the activity of the neuronal network. Although both cause an increase in the overall number of spikes, the distribution of spikes is different. While DOC2B enhances, Munc13-1 reduces the firing rate within bursts of spikes throughout the network; however, Munc13-1 increases the rate of network bursts. DOC2B's effects were mimicked by Strontium that elevates asynchronous release but not by a DOC2B mutant that enhances spontaneous release rate. This suggests for the first time that increased asynchronous release on the single-neuron level promotes bursting activity in the network level. This innovative study demonstrates the complementary role of the network level in explaining the physiological relevance of the cellular activity of presynaptic proteins and the transformation of synaptic release manipulation from the neuron to the network level.


Subject(s)
Action Potentials/physiology , Calcium-Binding Proteins/metabolism , Nerve Net/physiology , Nerve Tissue Proteins/metabolism , Neurons/physiology , Action Potentials/drug effects , Animals , Blotting, Western , Calcium-Binding Proteins/genetics , Cells, Cultured , Cerebral Cortex/drug effects , Cerebral Cortex/physiology , Computer Simulation , Immunohistochemistry , Mice, Inbred ICR , Microelectrodes , Mutation , Nerve Tissue Proteins/genetics , Neural Pathways/drug effects , Neural Pathways/physiology , Neurons/drug effects , Neurotransmitter Agents/pharmacology , Strontium/pharmacology
6.
Neuromolecular Med ; 15(2): 351-63, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23519441

ABSTRACT

Tomosyn, a syntaxin-binding protein, is known to inhibit vesicle priming and synaptic transmission via interference with the formation of SNARE complexes. Using a lentiviral vector, we specifically overexpressed tomosyn1 in hippocampal dentate gyrus neurons in adult mice. Mice were then subjected to spatial learning and memory tasks and electrophysiological measurements from hippocampal slices. Tomosyn1-overexpression significantly impaired hippocampus-dependent spatial memory while tested in the Morris water maze. Further, tomosyn1-overexpressing mice utilize swimming strategies of lesser cognitive ability in the Morris water maze compared with control mice. Electrophysiological measurements at mossy fiber-CA3 synapses revealed impaired paired-pulse facilitation in the mossy fiber of tomosyn1-overexpressing mice. This study provides evidence for novel roles for tomosyn1 in hippocampus-dependent spatial learning and memory, potentially via decreased synaptic transmission in mossy fiber-CA3 synapses. Moreover, it provides new insight regarding the role of the hippocampal dentate gyrus and mossy fiber-CA3 synapses in swimming strategy preference, and in learning and memory.


Subject(s)
CA3 Region, Hippocampal/physiopathology , Dentate Gyrus/physiopathology , Learning Disabilities/genetics , Memory Disorders/genetics , Nerve Tissue Proteins/physiology , R-SNARE Proteins/physiology , Animals , Bacterial Proteins/genetics , CA3 Region, Hippocampal/metabolism , Dentate Gyrus/metabolism , Exploratory Behavior/physiology , Genes, Reporter , Genetic Vectors , Learning Disabilities/physiopathology , Lentivirus , Luminescent Proteins/genetics , Male , Maze Learning , Memory Disorders/physiopathology , Mice , Mice, Inbred C57BL , Mossy Fibers, Hippocampal/physiopathology , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Neuronal Plasticity/physiology , Psychomotor Performance/physiology , R-SNARE Proteins/biosynthesis , R-SNARE Proteins/genetics , Recombinant Fusion Proteins/metabolism , Swimming , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...